|
|
|
|
|
Wen-Chin Ko, Chia-Ti Tsai, Kai-Cheng Hsu, Yu-Che Cheng, Tony Eight Lin, Yi-Ling Chen, Chuang-Ye Hong, Wan-Jung Lu, Chun-Ming Shih and Ting-Lin Yen
Treatment of magnolol represents a new therapeutic strategy that may reduce the risk of vascular diseases associated with abnormal vascular smooth muscle cell (VSMC) migration or thrombin/protease-activated receptor 1 (PAR-1) activation.
|
|
|
|
|
|
|
|
|
|
|
Kuo-Hua Lee, Jai-Wei Lee, Shih-Wen Wang, Lu-Yuan Liu, Mei-Fen Lee, Shih-Te Chuang, Yih-Min Shy, Chu-Li Chang, Ming-Che Wu, and Chau-Hwa Chi
Pág. 463 - 471
|
|
|
|
|
|
|
|
|
|
|
Hsin-Chien CHUANG, Jer-Haur KUO, Chien-Chia HUANG, Shih-Hsien LIU and Weng-Sing HWANG
Pág. 1158
|
|
|
|
|
|